The S&P 500 (^GSPC) has entered correction, falling 10% from its February all-time highs as political uncertainty has driven ...

UiPath (NYSE:PATH – Free Report) had its price target reduced by BMO Capital Markets from $16.00 to $11.50 in a report ...

BMO Capital Markets assumed coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a research note issued to investors on Wednesday, MarketBeat Ratings reports. The brokerage ...

On Thursday, BMO Capital Markets sustained their Market Perform rating on Casey’s General Stores (NASDAQ:CASY), with a steady price target of $450.00. The convenience store chain, currently ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...

U.S. services sector growth unexpectedly picked up in February and prices for inputs increased, which combined with a recent ...

First, I want to thank Joel and BMO for hosting us ... And around that, the markets that we serve around that particularly around mobility. Everyone thinks about EVs, but it's much broader ...

Economists had expected the unemployment rate to climb back up to 6.7 per cent in February, according to consensus estimates ...

On Friday, BMO Capital Markets maintained its "Market Perform" rating and a $25.00 price target for Gap Inc. (NYSE:GAP) shares, above the current trading price of $19.48. According to InvestingPro ...

Stock market corrections of 10% hurt. But research shows that they often don't portend worse things ahead for stocks.

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of $12 ...